artrosis total knee arthroplasty
Conditions
Interventions
During the trial blood will be collected from the patients pre and
postoperative (2, 4 and 6 hours and day 2 and 4 after surgery)
Sponsors
Maaslandziekenhuis
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - patients receiving a primary total knee arthroplasty - patients with osteoarthritis or avascular necrosis
Exclusion criteria
Exclusion criteria: - pregnancy - clinical relevant disorders, like rheumatoid arthritis, previous knee surgery, standard use of anticoagulantia - unwilling and unable to cooperate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin will be determined in terms of blood loss. Blood loss is also measured during the operation and post-operatively in terms of drainporduction. H-FABP tissue damage and IL-6 inflammation reactions Furthermore the patient will be standard evaluated in terms of range of motion, prothesis alignement and pain | — |
Secondary
| Measure | Time frame |
|---|---|
| None | — |
Countries
Netherlands
Outcome results
None listed